Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy
Saved in:
| Published in: | PLOS ONE |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy
- Evaluation of Paclitaxel and Cisplatin Combinations in TNBC: A Strategy to Enhance Efficacy and Minimize Exposure
- Germ cell tumours
- Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells
- Development of niosomal nanoparticles loaded with cisplatin and vorinostat combination for cancer therapy
- Multilayered analysis of cisplatin resistance mechanisms in bladder cancer: from the cell membrane to organelles
- Efficacy of Plasma ONE apparatus for disinfection of , and bacteria from the solid surface